BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11843819)

  • 1. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
    Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
    Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
    Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
    Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
    Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
    Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
    Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia.
    Lin K; Sherrington PD; Dennis M; Matrai Z; Cawley JC; Pettitt AR
    Blood; 2002 Aug; 100(4):1404-9. PubMed ID: 12149224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia.
    Thunberg U; Johnson A; Roos G; Thörn I; Tobin G; Sällström J; Sundström C; Rosenquist R
    Blood; 2001 Mar; 97(6):1892-4. PubMed ID: 11263438
    [No Abstract]   [Full Text] [Related]  

  • 7. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
    Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia.
    Matrai Z; Lin K; Dennis M; Sherrington P; Zuzel M; Pettitt AR; Cawley JC
    Blood; 2001 Mar; 97(6):1902-3. PubMed ID: 11263445
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoglobulin V genes and CD38 expression in CLL.
    Hamblin TJ; Orchard JA; Gardiner A; Oscier DG; Davis Z; Stevenson FK
    Blood; 2000 Apr; 95(7):2455-7. PubMed ID: 10787241
    [No Abstract]   [Full Text] [Related]  

  • 10. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
    Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
    Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
    Chevallier P; Penther D; Avet-Loiseau H; Robillard N; Ifrah N; Mahé B; Hamidou M; Maisonneuve H; Moreau P; Jardel H; Harousseau JL; Bataille R; Garand R
    Br J Haematol; 2002 Jan; 116(1):142-50. PubMed ID: 11841407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
    Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
    Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
    Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
    Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
    Damle RN; Wasil T; Fais F; Ghiotto F; Valetto A; Allen SL; Buchbinder A; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Vinciguerra VP; Rai KR; Ferrarini M; Chiorazzi N
    Blood; 1999 Sep; 94(6):1840-7. PubMed ID: 10477712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia.
    Hsi ED; Kopecky KJ; Appelbaum FR; Boldt D; Frey T; Loftus M; Hussein MA
    Br J Haematol; 2003 Mar; 120(6):1017-25. PubMed ID: 12648072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia.
    Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
    Eur J Haematol; 2003 Jan; 70(1):53-9. PubMed ID: 12631259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
    Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
    J Immunother; 2009 Apr; 32(3):302-9. PubMed ID: 19242370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.